Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Mar
17
2020
Consumer Brands Association Urges U.S. Government to Prevent Global Export Restrictions on Materials Needed to Treat and Prevent the Coronavirus Keller and Heckman LLP
Mar
16
2020
FDA Grants COVID-19 Diagnostic Emergency Use Authorizations, And Other Recent FDA Actions With to Address COVID-19 Sheppard, Mullin, Richter & Hampton LLP
Mar
16
2020
Thailand Considers Allowing Recycled Food-Contact Plastic, Requests Information Keller and Heckman LLP
Mar
16
2020
Coronavirus (COVID-19) Update for Pennsylvania Food and Beverage Businesses Norris McLaughlin P.A.
Mar
16
2020
TTB Relaxes Consignment Sale Restrictions in Wake of Coronavirus Cancellations McDermott Will & Emery
Mar
16
2020
INO v. Praxair – Time for the Supreme Court to Step Up to the Plate? Schwegman, Lundberg & Woessner, P.A.
Mar
13
2020
Coronavirus Survival Kit for Breweries and Restaurants Norris McLaughlin P.A.
Mar
13
2020
BRAG Biobased Products Blog: EPA Updates March 13, 2020 Bergeson & Campbell, P.C.
Mar
13
2020
FDA’s Launches Campaign on New Nutrition Facts Label Keller and Heckman LLP
Mar
13
2020
A Busy Sixth Circuit in “an Alice in Wonderland world” Squire Patton Boggs (US) LLP
Mar
12
2020
New Jersey Medical Marijuana User May Proceed With Discrimination Claim Jackson Lewis P.C.
Mar
12
2020
NJ Supreme Court Rules that the LAD Protects Registered Medical Cannabis Users Epstein Becker & Green, P.C.
Mar
12
2020
FDA Update: COVID-19 Testing, Vaccine Development and Other Impacts McDermott Will & Emery
Mar
12
2020
FDA Reiterates Potential Safety Risks of Using CBD Products Jackson Lewis P.C.
Mar
12
2020
FDA Will Postpone Most Foreign Inspections Through April 2020 in Response to the Ongoing Spread of the Coronavirus Keller and Heckman LLP
Mar
12
2020
FDA Reopens Public Docket Seeking Data on the Safety and Potential Benefits of CBD Beveridge & Diamond PC
Mar
11
2020
HSA Eligibility Not Disrupted By COVID-19 (Novel Coronavirus) Testing And Treatment McDermott Will & Emery
Mar
11
2020
IRS Loosens HSA Rules for Coronavirus Proskauer Rose LLP
Mar
11
2020
FTC and FDA Warn Companies About Coronavirus Treatment Claims Keller and Heckman LLP
Mar
11
2020
FDA Commissioner Signals Enforcement Policy, Advancement of Research for CBD Products Sheppard, Mullin, Richter & Hampton LLP
Mar
11
2020
FTC and FDA Send Warning Letters to Seven Companies about Unsupported Claims that Products Can Treat or Prevent Coronavirus Bergeson & Campbell, P.C.
Mar
11
2020
FDA Gives a CBD Update: Spoiler Alert! It’s More or Less the Same Old News Mintz
Mar
11
2020
A Recipe for Disaster: The Impact of COVID-19 on Food Safety and the Food Industry Bilzin Sumberg
Mar
11
2020
FDA Postpones Ex-US Facility Inspections Sheppard, Mullin, Richter & Hampton LLP
Mar
11
2020
Board Briefing: The Presidential Candidates' Healthcare Proposals McDermott Will & Emery
Mar
11
2020
EPA Announces Latest Update to TSCA Inventory Bergeson & Campbell, P.C.
Mar
11
2020
FDA and FTC Issue Warning Letters to Companies Selling Fraudulent Products to Treat or Prevent COVID-19 Keller and Heckman LLP
Mar
11
2020
Gin Manufacturer Bacardi Avoids Lawsuit for Its Use of “Grains of Paradise” Proskauer Rose LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins